Terms ending in 2036
Every in-force patent on DCB-USA LLC's record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,174,322 | Short Interfering RNA for Treating Cancer In force · High confidence | National Cheng Kung University | In force | High confidence | |
| US 10,980,853 | Process for Preparing a Crassocephalum Crepidioides Extract, Extract Prepared Thereby and Use of the Extract In force · High confidence | Development Center for Biotechnology | In force | High confidence | |
| US 10,633,453 | Antibody Locker for the Inactivation of Protein Drug In force · High confidence | DCB-USA LLC and Kaohsiung Medical University | In force | High confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by DCB-USA LLC.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.